Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Publications

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade

Milotay G. et al, (2025), Nature Medicine

Genome-wide association study of somatic GATA1s mutations in newborns with Down Syndrome.

Li Y. et al, (2025), Blood Adv

Prenatal treatment of spinal muscular atrophy.

Servais L., (2025), Mol Ther

Re-imagining combination vaccines for travel medicine

McGuinness SL. et al, (2025), Journal of Travel Medicine

The validity of test-negative design for assessment of typhoid conjugate vaccine protection: comparison of estimates by different study designs using data from a cluster-randomised controlled trial.

Feng S. et al, (2025), Lancet Glob Health

Systematic identification of disease-causing promoter and untranslated region variants in 8040 undiagnosed individuals with rare disease.

Martin-Geary AC. et al, (2025), Genome Med, 17

Plasmodium falciparum Subtilisin-Like Domain Containing Protein ((PfSDP) PF3D7_1105800), a Cross-Stage Antigen, Elicits Short-Lived Antibody Response Following Natural Infection with Plasmodium falciparum

Kengne-Ouafo JA. et al, (2025)

Cell-penetrating peptide-conjugated, splice-switching oligonucleotides mitigate the phenotype in BTK/Tec double deficient X-linked agammaglobulinemia model.

Bestas B. et al, (2025), RSC Chem Biol

Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AML.

Wang Z. et al, (2025), Blood

Confronting the shortcomings of covid-19 vaccination will help us in future pandemics.

Vanderslott S., (2025), BMJ, 388

The effect of pertussis vaccination in pregnancy on the immunogenicity of acellular or whole-cell pertussis vaccination in Gambian infants (GaPS): a single-centre, randomised, controlled, double-blind, phase 4 trial.

Saso A. et al, (2025), Lancet Infect Dis

Altered chaperone-nonmuscle myosin II interactions drive pathogenicity of the UNC45A c.710T>C variant in osteo-oto-hepato-enteric syndrome.

Waich S. et al, (2025), JCI Insight, 10

Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.

Cheerie D. et al, (2025), Am J Hum Genet

Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.

Mellors J. et al, (2025), Nat Commun, 16

Epidemiology of Group B Streptococcus: Maternal Colonization and Infant Disease in Kampala, Uganda

Kyohere M. et al, (2025), Open Forum Infectious Diseases

Dystrophin isoform deficiency and upper-limb and respiratory function in Duchenne muscular dystrophy.

Chesshyre M. et al, (2025), Dev Med Child Neurol

Acceptability of the gonorrhoea human challenge model to accelerate vaccine development in UK men.

Firth C. et al, (2025), Vaccine, 54

Targeted BDNF upregulation via upstream open reading frame disruption

Feng N. et al, (2025)

Contribution of autosomal rare and de novo variants to sex differences in autism

Koko M. et al, (2025), American Journal of Human Genetics, 112, 599 - 614

X-linked myotubular myopathy: an untreated treatable disease.

Martin C. and Servais L., (2025), Expert Opin Biol Ther, 1 - 16

Load More